招银国际成功保荐中慧元通IPO发行并在香港联交所主板挂牌上市

招银国际
Aug 11

交易概述2025年8月11日,江苏中慧元通生物科技股份有限公司(“中慧元通”,2627.HK)成功在香港联合交易所主板挂牌上市。招银国际担任中慧元通在香港IPO的联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。中慧元通此次全球发行33,442,600股H股,发行价格为每股12.90港元,总募集金额约4.31亿港元。本次发行引入了一名基石投资人,为嘉兴鑫扬,其认购金额为1,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10